VELCADE
Live / Registered — Registered and renewed (as of 11 Dec 2018)
What this means for you
Registered since 21 Jul 2009. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Jul 2019).
Record
- Serial number
- 77445948
- Registration number
- 3659030
- Mark type
- Design + words
- Filed
- 11 Apr 2008
- Published for opposition
- 07 Oct 2008
- Registered
- 21 Jul 2009
- Next maintenance due
- 21 Jul 2019
- Attorney of record
- Nancy C. DiConza
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, proteasome inhibitors; pharmaceutical preparations for treatment of myelomas [, leukemias] and cancers; pharmaceutical preparations for use in chemotherapy
Owner
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 11 Dec 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 11 Dec 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 11 Dec 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 11 Dec 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Nov 2018 — TEAS SECTION 8 & 9 RECEIVED
- 21 Jul 2018 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Feb 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Feb 2016 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 02 Feb 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Nov 2015 — TEAS SECTION 8 & 15 RECEIVED
- 21 Jul 2009 — REGISTERED-PRINCIPAL REGISTER
- 12 Jun 2009 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 29 May 2009 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED